ID   ST1A2_HUMAN             Reviewed;         295 AA.
AC   P50226; A9QY25; P78393; Q14CJ7;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   09-FEB-2010, sequence version 2.
DT   10-MAY-2017, entry version 151.
DE   RecName: Full=Sulfotransferase 1A2;
DE            Short=ST1A2;
DE            EC=2.8.2.1;
DE   AltName: Full=Aryl sulfotransferase 2;
DE   AltName: Full=Phenol sulfotransferase 2;
DE   AltName: Full=Phenol-sulfating phenol sulfotransferase 2;
DE            Short=P-PST 2;
GN   Name=SULT1A2; Synonyms=STP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS THR-7; THR-235 AND GLU-282.
RC   TISSUE=Liver;
RX   PubMed=8697101; DOI=10.1016/1357-2725(95)00164-6;
RA   Zhu X., Veronese M.E., Iocco P., McManus M.E.;
RT   "cDNA cloning and expression of a new form of human aryl
RT   sulfotransferase.";
RL   Int. J. Biochem. Cell Biol. 28:565-571(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS LEU-19 AND GLU-282.
RC   TISSUE=Liver;
RX   PubMed=7581483;
RA   Ozawa S., Nagata K., Shimada M., Ueda M., Tsuzuki T., Yamazoe Y.,
RA   Kato R.;
RT   "Primary structures and properties of two related forms of aryl
RT   sulfotransferases in human liver.";
RL   Pharmacogenetics 5:S135-S140(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8033246; DOI=10.1016/0009-2797(94)90057-4;
RA   Yamazoe Y., Nagata K., Ozawa S., Kato R.;
RT   "Structural similarity and diversity of sulfotransferases.";
RL   Chem. Biol. Interact. 92:107-117(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GLU-282.
RX   PubMed=8661000; DOI=10.1006/geno.1996.0216;
RA   Her C., Raftogianis R., Weinshilboum R.M.;
RT   "Human phenol sulfotransferase STP2 gene: molecular cloning,
RT   structural characterization, and chromosomal localization.";
RL   Genomics 33:409-420(1996).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS THR-7; THR-235 AND
RP   GLU-282.
RX   PubMed=8912648; DOI=10.1006/bbrc.1996.1628;
RA   Dooley T.P., Huang Z.;
RT   "Genomic organization and DNA sequences of two human phenol
RT   sulfotransferase genes (STP1 and STP2) on the short arm of chromosome
RT   16.";
RL   Biochem. Biophys. Res. Commun. 228:134-140(1996).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS THR-7; THR-235 AND
RP   GLU-282.
RX   PubMed=9119390; DOI=10.1006/geno.1996.4575;
RA   Gaedigk A., Beatty B.G., Grant D.M.;
RT   "Cloning, structural organization, and chromosomal mapping of the
RT   human phenol sulfotransferase STP2 gene.";
RL   Genomics 40:242-246(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLU-282.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   CHARACTERIZATION.
RX   PubMed=7889867; DOI=10.1289/ehp.94102s699;
RA   Yamazoe Y., Ozawa S., Nagata K., Gong D.-W., Kato R.;
RT   "Characterization and expression of hepatic sulfotransferase involved
RT   in the metabolism of N-substituted aryl compounds.";
RL   Environ. Health Perspect. 102:99-103(1994).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) IN COMPLEX WITH
RP   ADENOSINE-3'-5'-DIPHOSPHATE, AND CATALYTIC ACTIVITY.
RX   PubMed=20417180; DOI=10.1016/j.bbrc.2010.04.109;
RA   Lu J., Li H., Zhang J., Li M., Liu M.Y., An X., Liu M.C., Chang W.;
RT   "Crystal structures of SULT1A2 and SULT1A1 *3: insights into the
RT   substrate inhibition and the role of Tyr149 in SULT1A2.";
RL   Biochem. Biophys. Res. Commun. 396:429-434(2010).
RN   [11]
RP   VARIANT THR-235.
RX   PubMed=10762004; DOI=10.1097/00008571-200003000-00008;
RA   Engelke C.E., Meinl W., Boeing H., Glatt H.;
RT   "Association between functional genetic polymorphisms of human
RT   sulfotransferases 1A1 and 1A2.";
RL   Pharmacogenetics 10:163-169(2000).
CC   -!- FUNCTION: Sulfotransferase that utilizes 3'-phospho-5'-adenylyl
CC       sulfate (PAPS) as sulfonate donor to catalyze the sulfate
CC       conjugation of catecholamines, phenolic drugs and
CC       neurotransmitters. Is also responsible for the sulfonation and
CC       activation of minoxidil. Mediates the metabolic activation of
CC       carcinogenic N-hydroxyarylamines to DNA binding products and could
CC       so participate as modulating factor of cancer risk.
CC   -!- CATALYTIC ACTIVITY: 3'-phosphoadenylyl sulfate + a phenol =
CC       adenosine 3',5'-bisphosphate + an aryl sulfate.
CC       {ECO:0000269|PubMed:20417180}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9GZT8:NIF3L1; NbExp=3; IntAct=EBI-6137631, EBI-740897;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- SIMILARITY: Belongs to the sulfotransferase 1 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U28170; AAB09659.1; -; mRNA.
DR   EMBL; U28169; AAB09658.1; -; mRNA.
DR   EMBL; X78282; CAA55088.1; -; mRNA.
DR   EMBL; U34804; AAB09758.1; -; Genomic_DNA.
DR   EMBL; U72202; AAB08970.1; -; Genomic_DNA.
DR   EMBL; U72196; AAB08970.1; JOINED; Genomic_DNA.
DR   EMBL; U72197; AAB08970.1; JOINED; Genomic_DNA.
DR   EMBL; U72198; AAB08970.1; JOINED; Genomic_DNA.
DR   EMBL; U72199; AAB08970.1; JOINED; Genomic_DNA.
DR   EMBL; U72200; AAB08970.1; JOINED; Genomic_DNA.
DR   EMBL; U72201; AAB08970.1; JOINED; Genomic_DNA.
DR   EMBL; U76619; AAB18753.1; -; Genomic_DNA.
DR   EMBL; U33886; AAC51149.1; -; Genomic_DNA.
DR   EMBL; U33886; ABX65442.1; -; Genomic_DNA.
DR   EMBL; AC020765; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC113727; AAI13728.1; -; mRNA.
DR   EMBL; BC113729; AAI13730.1; -; mRNA.
DR   CCDS; CCDS10636.1; -.
DR   PIR; G01843; G01843.
DR   PIR; JC5249; JC5249.
DR   PIR; S52791; S52791.
DR   RefSeq; NP_001045.1; NM_001054.3.
DR   RefSeq; NP_803564.1; NM_177528.2.
DR   UniGene; Hs.546304; -.
DR   PDB; 1Z29; X-ray; 2.40 A; A=1-295.
DR   PDBsum; 1Z29; -.
DR   ProteinModelPortal; P50226; -.
DR   SMR; P50226; -.
DR   BioGrid; 112673; 9.
DR   IntAct; P50226; 1.
DR   STRING; 9606.ENSP00000338742; -.
DR   ChEMBL; CHEMBL1743292; -.
DR   iPTMnet; P50226; -.
DR   PhosphoSitePlus; P50226; -.
DR   BioMuta; SULT1A2; -.
DR   DMDM; 288558827; -.
DR   EPD; P50226; -.
DR   MaxQB; P50226; -.
DR   PaxDb; P50226; -.
DR   PeptideAtlas; P50226; -.
DR   PRIDE; P50226; -.
DR   Ensembl; ENST00000335715; ENSP00000338742; ENSG00000197165.
DR   Ensembl; ENST00000395630; ENSP00000378992; ENSG00000197165.
DR   GeneID; 6799; -.
DR   KEGG; hsa:6799; -.
DR   UCSC; uc002dqg.3; human.
DR   CTD; 6799; -.
DR   DisGeNET; 6799; -.
DR   GeneCards; SULT1A2; -.
DR   HGNC; HGNC:11454; SULT1A2.
DR   HPA; HPA049500; -.
DR   HPA; HPA051051; -.
DR   MIM; 601292; gene.
DR   neXtProt; NX_P50226; -.
DR   OpenTargets; ENSG00000197165; -.
DR   PharmGKB; PA341; -.
DR   eggNOG; KOG1584; Eukaryota.
DR   eggNOG; ENOG4111H56; LUCA.
DR   GeneTree; ENSGT00760000118932; -.
DR   HOGENOM; HOG000037209; -.
DR   HOVERGEN; HBG001195; -.
DR   InParanoid; P50226; -.
DR   KO; K01014; -.
DR   OMA; ILEFVGH; -.
DR   OrthoDB; EOG091G0D5F; -.
DR   PhylomeDB; P50226; -.
DR   TreeFam; TF321745; -.
DR   BioCyc; MetaCyc:HS11091-MONOMER; -.
DR   BRENDA; 2.8.2.1; 2681.
DR   BRENDA; 2.8.2.9; 2681.
DR   Reactome; R-HSA-156584; Cytosolic sulfonation of small molecules.
DR   SABIO-RK; P50226; -.
DR   EvolutionaryTrace; P50226; -.
DR   GeneWiki; SULT1A2; -.
DR   GenomeRNAi; 6799; -.
DR   PRO; PR:P50226; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000197165; -.
DR   CleanEx; HS_SULT1A2; -.
DR   ExpressionAtlas; P50226; baseline and differential.
DR   Genevisible; P50226; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0004062; F:aryl sulfotransferase activity; IDA:UniProtKB.
DR   GO; GO:0047894; F:flavonol 3-sulfotransferase activity; IDA:BHF-UCL.
DR   GO; GO:0008146; F:sulfotransferase activity; TAS:Reactome.
DR   GO; GO:0050427; P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; IDA:CAFA.
DR   GO; GO:0009309; P:amine biosynthetic process; TAS:ProtInc.
DR   GO; GO:0006584; P:catecholamine metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006068; P:ethanol catabolic process; IDA:CAFA.
DR   GO; GO:0018958; P:phenol-containing compound metabolic process; IDA:UniProtKB.
DR   GO; GO:0008202; P:steroid metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0051923; P:sulfation; IDA:BHF-UCL.
DR   GO; GO:0006805; P:xenobiotic metabolic process; IDA:UniProtKB.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR000863; Sulfotransferase_dom.
DR   Pfam; PF00685; Sulfotransfer_1; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Catecholamine metabolism; Complete proteome; Cytoplasm;
KW   Lipid metabolism; Polymorphism; Reference proteome;
KW   Steroid metabolism; Transferase.
FT   CHAIN         1    295       Sulfotransferase 1A2.
FT                                /FTId=PRO_0000085128.
FT   NP_BIND      48     53       PAPS.
FT   NP_BIND     227    232       PAPS.
FT   NP_BIND     255    259       PAPS.
FT   REGION      106    108       Substrate binding. {ECO:0000250}.
FT   ACT_SITE    108    108       Proton acceptor. {ECO:0000250}.
FT   BINDING     130    130       PAPS.
FT   BINDING     138    138       PAPS.
FT   BINDING     193    193       PAPS.
FT   VARIANT       7      7       I -> T (in dbSNP:rs1136703).
FT                                {ECO:0000269|PubMed:8697101,
FT                                ECO:0000269|PubMed:8912648,
FT                                ECO:0000269|PubMed:9119390}.
FT                                /FTId=VAR_007426.
FT   VARIANT      19     19       P -> L (in dbSNP:rs10797300).
FT                                {ECO:0000269|PubMed:7581483}.
FT                                /FTId=VAR_057340.
FT   VARIANT      62     62       Y -> F (in dbSNP:rs4987024).
FT                                /FTId=VAR_057341.
FT   VARIANT     235    235       N -> T (in dbSNP:rs1059491).
FT                                {ECO:0000269|PubMed:10762004,
FT                                ECO:0000269|PubMed:8697101,
FT                                ECO:0000269|PubMed:8912648,
FT                                ECO:0000269|PubMed:9119390}.
FT                                /FTId=VAR_007427.
FT   VARIANT     239    239       N -> S (in dbSNP:rs45472392).
FT                                /FTId=VAR_057342.
FT   VARIANT     282    282       K -> E (in dbSNP:rs27742).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:7581483,
FT                                ECO:0000269|PubMed:8661000,
FT                                ECO:0000269|PubMed:8697101,
FT                                ECO:0000269|PubMed:8912648,
FT                                ECO:0000269|PubMed:9119390}.
FT                                /FTId=VAR_061887.
FT   CONFLICT    290    290       S -> T (in Ref. 6; AAC51149/ABX65442).
FT                                {ECO:0000305}.
FT   STRAND       13     15       {ECO:0000244|PDB:1Z29}.
FT   STRAND       18     20       {ECO:0000244|PDB:1Z29}.
FT   HELIX        22     26       {ECO:0000244|PDB:1Z29}.
FT   HELIX        30     32       {ECO:0000244|PDB:1Z29}.
FT   STRAND       41     46       {ECO:0000244|PDB:1Z29}.
FT   HELIX        51     62       {ECO:0000244|PDB:1Z29}.
FT   HELIX        75     78       {ECO:0000244|PDB:1Z29}.
FT   HELIX        92     95       {ECO:0000244|PDB:1Z29}.
FT   TURN         96     98       {ECO:0000244|PDB:1Z29}.
FT   STRAND      104    107       {ECO:0000244|PDB:1Z29}.
FT   TURN        111    113       {ECO:0000244|PDB:1Z29}.
FT   HELIX       116    120       {ECO:0000244|PDB:1Z29}.
FT   STRAND      124    129       {ECO:0000244|PDB:1Z29}.
FT   HELIX       132    145       {ECO:0000244|PDB:1Z29}.
FT   HELIX       155    163       {ECO:0000244|PDB:1Z29}.
FT   HELIX       172    182       {ECO:0000244|PDB:1Z29}.
FT   TURN        183    185       {ECO:0000244|PDB:1Z29}.
FT   STRAND      188    192       {ECO:0000244|PDB:1Z29}.
FT   HELIX       193    198       {ECO:0000244|PDB:1Z29}.
FT   HELIX       200    210       {ECO:0000244|PDB:1Z29}.
FT   HELIX       217    226       {ECO:0000244|PDB:1Z29}.
FT   HELIX       229    234       {ECO:0000244|PDB:1Z29}.
FT   TURN        236    238       {ECO:0000244|PDB:1Z29}.
FT   TURN        245    247       {ECO:0000244|PDB:1Z29}.
FT   TURN        250    252       {ECO:0000244|PDB:1Z29}.
FT   HELIX       263    266       {ECO:0000244|PDB:1Z29}.
FT   HELIX       270    283       {ECO:0000244|PDB:1Z29}.
SQ   SEQUENCE   295 AA;  34310 MW;  EB505BBDAA3A2E09 CRC64;
     MELIQDISRP PLEYVKGVPL IKYFAEALGP LQSFQARPDD LLISTYPKSG TTWVSQILDM
     IYQGGDLEKC HRAPIFMRVP FLEFKVPGIP SGMETLKNTP APRLLKTHLP LALLPQTLLD
     QKVKVVYVAR NAKDVAVSYY HFYHMAKVYP HPGTWESFLE KFMAGEVSYG SWYQHVQEWW
     ELSRTHPVLY LFYEDMKENP KREIQKILEF VGRSLPEETV DLMVEHTSFK EMKKNPMTNY
     TTVRREFMDH SISPFMRKGM AGDWKTTFTV AQNERFDADY AKKMAGCSLS FRSEL
//
